Increasing the performance of pooled CRISPR–Cas9 drop-out screening

Components of the type II CRISPR–Cas complex in bacteria have been used successfully in eukaryotic cells to facilitate rapid and accurate cell line engineering, animal model generation and functional genomic screens. Such developments are providing new opportunities for drug target identification an...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 6; no. 1; p. 31782
Main Authors Cross, Benedict C. S., Lawo, Steffen, Archer, Caroline R., Hunt, Jessica R., Yarker, Joanne L., Riccombeni, Alessandro, Little, Annette S., McCarthy, Nicola J., Moore, Jonathan D.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 22.08.2016
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN2045-2322
2045-2322
DOI10.1038/srep31782

Cover

Abstract Components of the type II CRISPR–Cas complex in bacteria have been used successfully in eukaryotic cells to facilitate rapid and accurate cell line engineering, animal model generation and functional genomic screens. Such developments are providing new opportunities for drug target identification and validation, particularly with the application of pooled genetic screening. As CRISPR–Cas is a relatively new genetic screening tool, it is important to assess its functionality in a number of different cell lines and to analyse potential improvements that might increase the sensitivity of a given screen. To examine critical aspects of screening quality, we constructed ultra-complex libraries containing sgRNA sequences targeting a collection of essential genes. We examined the performance of screening in both haploid and hypotriploid cell lines, using two alternative guide design algorithms and two tracrRNA variants in a time-resolved analysis. Our data indicate that a simple adaptation of the tracrRNA substantially improves the robustness of guide loss during a screen. This modification minimises the requirement for high numbers of sgRNAs targeting each gene, increasing hit scoring and creating a powerful new platform for successful screening.
AbstractList Components of the type II CRISPR–Cas complex in bacteria have been used successfully in eukaryotic cells to facilitate rapid and accurate cell line engineering, animal model generation and functional genomic screens. Such developments are providing new opportunities for drug target identification and validation, particularly with the application of pooled genetic screening. As CRISPR–Cas is a relatively new genetic screening tool, it is important to assess its functionality in a number of different cell lines and to analyse potential improvements that might increase the sensitivity of a given screen. To examine critical aspects of screening quality, we constructed ultra-complex libraries containing sgRNA sequences targeting a collection of essential genes. We examined the performance of screening in both haploid and hypotriploid cell lines, using two alternative guide design algorithms and two tracrRNA variants in a time-resolved analysis. Our data indicate that a simple adaptation of the tracrRNA substantially improves the robustness of guide loss during a screen. This modification minimises the requirement for high numbers of sgRNAs targeting each gene, increasing hit scoring and creating a powerful new platform for successful screening.
ArticleNumber 31782
Author Riccombeni, Alessandro
McCarthy, Nicola J.
Hunt, Jessica R.
Moore, Jonathan D.
Lawo, Steffen
Archer, Caroline R.
Yarker, Joanne L.
Little, Annette S.
Cross, Benedict C. S.
Author_xml – sequence: 1
  givenname: Benedict C. S.
  surname: Cross
  fullname: Cross, Benedict C. S.
  email: Benedict.Cross@horizondiscovery.com
  organization: Horizon Discovery, 8100 Cambridge Research Park
– sequence: 2
  givenname: Steffen
  surname: Lawo
  fullname: Lawo, Steffen
  organization: Horizon Discovery, 8100 Cambridge Research Park
– sequence: 3
  givenname: Caroline R.
  surname: Archer
  fullname: Archer, Caroline R.
  organization: Horizon Discovery, 8100 Cambridge Research Park, Present address: AstraZeneca, The Darwin Building, Milton Rd, Milton, Cambridge CB4 0FZ, United Kingdom
– sequence: 4
  givenname: Jessica R.
  surname: Hunt
  fullname: Hunt, Jessica R.
  organization: Horizon Discovery, 8100 Cambridge Research Park, Present address: CRUK MedImmune Alliance Lab, Portway Building, Cambridge CB21 6GS, United Kingdom
– sequence: 5
  givenname: Joanne L.
  surname: Yarker
  fullname: Yarker, Joanne L.
  organization: Horizon Discovery, 8100 Cambridge Research Park
– sequence: 6
  givenname: Alessandro
  surname: Riccombeni
  fullname: Riccombeni, Alessandro
  organization: Horizon Discovery, 8100 Cambridge Research Park, Present address: DNAnexus, 1975 W El Camino Real #101, Mountain View, CA 94040, United States
– sequence: 7
  givenname: Annette S.
  surname: Little
  fullname: Little, Annette S.
  organization: Horizon Discovery, 8100 Cambridge Research Park
– sequence: 8
  givenname: Nicola J.
  surname: McCarthy
  fullname: McCarthy, Nicola J.
  organization: Horizon Discovery, 8100 Cambridge Research Park
– sequence: 9
  givenname: Jonathan D.
  surname: Moore
  fullname: Moore, Jonathan D.
  organization: Horizon Discovery, 8100 Cambridge Research Park
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27545104$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1KxDAUhYMo_i98AelShWpuktpkI8gw6oCg-LMOaSYdK52kJq3iznfwDX0SM8w4jiJmcwP3O-fenGygZeusQWgH8CFgyo-CNw2FnJMltE4wy1JCCVleuK-h7RAecTwZEQzEKlojecYywGwd9QdWe6NCZUdJ-2CSxvjS-bGy2iSuTBrnajNMejeD2-ubj7f3ngoiGXrXpK5rkxClxkbpFlopVR3M9qxuovuz_l3vIr28Oh_0Ti9TzQC3aV7kqiCizDnLhCacF0AAEwWgdaxYCABQ6niouGCGl1wDpyVQjWken1rQTXQw9e1so15fVF3Lxldj5V8lYDmJQ87jiPDJFG66YmyG2tjWq2-BU5X82bHVgxy5Z8mEIFxMDPZmBt49dSa0clwFbepaWeO6IIEDPSZAKIvo7uKs-ZCvoCOwPwW0dyHuWP67-NEvVletais3WbOq_1TMcgnR1Y6Ml4-u8zZ-xR_wJ27CrVE
CitedBy_id crossref_primary_10_1126_scitranslmed_abh1486
crossref_primary_10_1002_mc_23560
crossref_primary_10_1038_s41467_024_47987_x
crossref_primary_10_1177_2472555219883621
crossref_primary_10_1016_j_isci_2025_111884
crossref_primary_10_1038_s41419_021_04191_9
crossref_primary_10_1038_s41598_019_46952_9
crossref_primary_10_1371_journal_pbio_3002767
crossref_primary_10_3389_fonc_2022_852980
crossref_primary_10_1038_s41598_017_18172_6
crossref_primary_10_15252_msb_202211267
crossref_primary_10_1038_s41598_017_07827_z
crossref_primary_10_1093_nar_gkab309
crossref_primary_10_1038_s42255_021_00386_8
crossref_primary_10_1073_pnas_2316447121
crossref_primary_10_1038_s41467_018_07901_8
crossref_primary_10_1002_2211_5463_13482
crossref_primary_10_1016_j_ebiom_2020_103039
crossref_primary_10_1016_j_ccell_2021_06_018
crossref_primary_10_1016_j_molcel_2017_09_017
crossref_primary_10_1016_j_ymeth_2017_03_008
crossref_primary_10_1016_j_jmb_2018_06_034
crossref_primary_10_1089_crispr_2019_0066
Cites_doi 10.1016/j.cell.2015.11.015
10.1038/nrg3899
10.1101/gr.177220.114
10.1016/j.cell.2013.12.001
10.1186/s13059-014-0554-4
10.1126/science.1247005
10.1126/science.1225829
10.1186/s13059-015-0843-6
10.1126/science.1246981
10.1038/nrmicro1793
10.1016/B978-0-12-801185-0.00016-7
10.1038/nature10886
10.1016/j.drudis.2014.12.016
10.1038/nmeth.3047
10.1126/science.1258096
10.1101/033068
10.1038/nbt.3536
ContentType Journal Article
Copyright The Author(s) 2016
Copyright © 2016, The Author(s) 2016 The Author(s)
Copyright_xml – notice: The Author(s) 2016
– notice: Copyright © 2016, The Author(s) 2016 The Author(s)
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
DOI 10.1038/srep31782
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

CrossRef
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: SpringerLink Open Access Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 31782
ExternalDocumentID 10.1038/srep31782
PMC4992892
27545104
10_1038_srep31782
Genre Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
EJD
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
AFFHD
IPNFZ
RIG
UNPAY
ID FETCH-LOGICAL-c410t-7b7ab29f78459c288b12102a11cc102099111aa6da894e8f8c183f13c037038b3
IEDL.DBID M48
ISSN 2045-2322
IngestDate Wed Oct 29 11:34:25 EDT 2025
Tue Sep 30 16:26:36 EDT 2025
Fri Sep 05 06:21:46 EDT 2025
Mon Jul 21 05:33:49 EDT 2025
Wed Oct 01 02:20:00 EDT 2025
Thu Apr 24 23:11:25 EDT 2025
Fri Feb 21 02:38:26 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
cc-by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c410t-7b7ab29f78459c288b12102a11cc102099111aa6da894e8f8c183f13c037038b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: AstraZeneca, The Darwin Building, Milton Rd, Milton, Cambridge CB4 0FZ, United Kingdom.
Present address: DNAnexus, 1975 W El Camino Real #101, Mountain View, CA 94040, United States.
Present address: CRUK MedImmune Alliance Lab, Portway Building, Cambridge CB21 6GS, United Kingdom.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/srep31782
PMID 27545104
PQID 1813621234
PQPubID 23479
PageCount 1
ParticipantIDs unpaywall_primary_10_1038_srep31782
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4992892
proquest_miscellaneous_1813621234
pubmed_primary_27545104
crossref_primary_10_1038_srep31782
crossref_citationtrail_10_1038_srep31782
springer_journals_10_1038_srep31782
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20160822
2016-08-22
2016-Aug-22
PublicationDateYYYYMMDD 2016-08-22
PublicationDate_xml – month: 8
  year: 2016
  text: 20160822
  day: 22
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2016
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Sanjana, Shalem, Zhang (CR10) 2014; 11
Shalem (CR13) 2014; 343
Li (CR6) 2015; 16
CR5
Essletzbichler (CR15) 2014; 24
Hart (CR16) 2015; 163
Chen, Huang (CR12) 2014; 546
CR17
CR9
Doudna, Charpentier (CR4) 2014; 346
Chen (CR14) 2013; 155
Jinek (CR18) 2012; 337
Wang, Wei, Sabatini, Lander (CR11) 2014; 343
Shalem, Sanjana, Zhang (CR3) 2015; 16
Wiedenheft, Sternberg, Doudna (CR2) 2012; 482
Sorek, Kunin, Hugenholtz (CR1) 2008; 6
Li (CR8) 2014; 15
Moore (CR7) 2015; 20
NE Sanjana (BFsrep31782_CR10) 2014; 11
B Chen (BFsrep31782_CR14) 2013; 155
T Wang (BFsrep31782_CR11) 2014; 343
BFsrep31782_CR9
R Sorek (BFsrep31782_CR1) 2008; 6
W Li (BFsrep31782_CR8) 2014; 15
P Essletzbichler (BFsrep31782_CR15) 2014; 24
B Wiedenheft (BFsrep31782_CR2) 2012; 482
T Hart (BFsrep31782_CR16) 2015; 163
BFsrep31782_CR17
W Li (BFsrep31782_CR6) 2015; 16
JD Moore (BFsrep31782_CR7) 2015; 20
O Shalem (BFsrep31782_CR13) 2014; 343
BFsrep31782_CR5
JA Doudna (BFsrep31782_CR4) 2014; 346
M Jinek (BFsrep31782_CR18) 2012; 337
O Shalem (BFsrep31782_CR3) 2015; 16
B Chen (BFsrep31782_CR12) 2014; 546
References_xml – volume: 163
  start-page: 1515
  year: 2015
  end-page: 1526
  ident: CR16
  article-title: High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
  publication-title: Cell
  doi: 10.1016/j.cell.2015.11.015
– volume: 16
  start-page: 299
  year: 2015
  end-page: 311
  ident: CR3
  article-title: High-throughput functional genomics using CRISPR–Cas9
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg3899
– volume: 24
  start-page: 2059
  year: 2014
  end-page: 2065
  ident: CR15
  article-title: Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line
  publication-title: Genome Res.
  doi: 10.1101/gr.177220.114
– volume: 155
  start-page: 1479
  year: 2013
  end-page: 1491
  ident: CR14
  article-title: Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system
  publication-title: Cell
  doi: 10.1016/j.cell.2013.12.001
– volume: 15
  start-page: 554
  year: 2014
  ident: CR8
  article-title: MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
  publication-title: Genome Biol.
  doi: 10.1186/s13059-014-0554-4
– volume: 343
  start-page: 84
  year: 2014
  end-page: 87
  ident: CR13
  article-title: Genome-Scale CRISPR–Cas9 Knockout Screening in Human Cells
  publication-title: Science
  doi: 10.1126/science.1247005
– volume: 337
  start-page: 816
  year: 2012
  end-page: 822
  ident: CR18
  article-title: A Programmable Dual-RNA – Guided DNA Endonuclease in Adaptice Bacterial Immunity
  publication-title: Science
  doi: 10.1126/science.1225829
– volume: 16
  start-page: 281
  year: 2015
  ident: CR6
  article-title: Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR
  publication-title: Genome Biol.
  doi: 10.1186/s13059-015-0843-6
– volume: 343
  start-page: 80
  year: 2014
  end-page: 84
  ident: CR11
  article-title: Genetic screens in human cells using the CRISPR–Cas9 system
  publication-title: Science
  doi: 10.1126/science.1246981
– ident: CR17
– volume: 6
  start-page: 181
  year: 2008
  end-page: 186
  ident: CR1
  article-title: CRISPR--a widespread system that provides acquired resistance against phages in bacteria and archaea
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/nrmicro1793
– volume: 546
  start-page: 337
  year: 2014
  end-page: 354
  ident: CR12
  article-title: Imaging genomic elements in living cells using CRISPR/Cas9
  publication-title: Methods Enzymol.
  doi: 10.1016/B978-0-12-801185-0.00016-7
– ident: CR9
– volume: 482
  start-page: 331
  year: 2012
  end-page: 338
  ident: CR2
  article-title: RNA-guided genetic silencing systems in bacteria and archaea
  publication-title: Nature
  doi: 10.1038/nature10886
– volume: 20
  start-page: 450
  year: 2015
  end-page: 457
  ident: CR7
  article-title: The impact of CRISPR–Cas9 on target identification and validation
  publication-title: Drug Discov. Today
  doi: 10.1016/j.drudis.2014.12.016
– ident: CR5
– volume: 11
  start-page: 783
  year: 2014
  end-page: 784
  ident: CR10
  article-title: Improved vectors and genome-wide libraries for CRISPR screening
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3047
– volume: 346
  start-page: 1258096
  year: 2014
  end-page: 1258096
  ident: CR4
  article-title: The new frontier of genome engineering with CRISPR–Cas9
  publication-title: Science (80)
  doi: 10.1126/science.1258096
– volume: 346
  start-page: 1258096
  year: 2014
  ident: BFsrep31782_CR4
  publication-title: Science (80)
  doi: 10.1126/science.1258096
– volume: 343
  start-page: 84
  year: 2014
  ident: BFsrep31782_CR13
  publication-title: Science
  doi: 10.1126/science.1247005
– ident: BFsrep31782_CR9
  doi: 10.1101/033068
– volume: 16
  start-page: 281
  year: 2015
  ident: BFsrep31782_CR6
  publication-title: Genome Biol.
  doi: 10.1186/s13059-015-0843-6
– volume: 337
  start-page: 816
  year: 2012
  ident: BFsrep31782_CR18
  publication-title: Science
  doi: 10.1126/science.1225829
– volume: 6
  start-page: 181
  year: 2008
  ident: BFsrep31782_CR1
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/nrmicro1793
– volume: 343
  start-page: 80
  year: 2014
  ident: BFsrep31782_CR11
  publication-title: Science
  doi: 10.1126/science.1246981
– volume: 16
  start-page: 299
  year: 2015
  ident: BFsrep31782_CR3
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg3899
– volume: 15
  start-page: 554
  year: 2014
  ident: BFsrep31782_CR8
  publication-title: Genome Biol.
  doi: 10.1186/s13059-014-0554-4
– volume: 546
  start-page: 337
  year: 2014
  ident: BFsrep31782_CR12
  publication-title: Methods Enzymol.
  doi: 10.1016/B978-0-12-801185-0.00016-7
– volume: 24
  start-page: 2059
  year: 2014
  ident: BFsrep31782_CR15
  publication-title: Genome Res.
  doi: 10.1101/gr.177220.114
– volume: 482
  start-page: 331
  year: 2012
  ident: BFsrep31782_CR2
  publication-title: Nature
  doi: 10.1038/nature10886
– ident: BFsrep31782_CR5
  doi: 10.1038/nbt.3536
– ident: BFsrep31782_CR17
– volume: 20
  start-page: 450
  year: 2015
  ident: BFsrep31782_CR7
  publication-title: Drug Discov. Today
  doi: 10.1016/j.drudis.2014.12.016
– volume: 11
  start-page: 783
  year: 2014
  ident: BFsrep31782_CR10
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3047
– volume: 155
  start-page: 1479
  year: 2013
  ident: BFsrep31782_CR14
  publication-title: Cell
  doi: 10.1016/j.cell.2013.12.001
– volume: 163
  start-page: 1515
  year: 2015
  ident: BFsrep31782_CR16
  publication-title: Cell
  doi: 10.1016/j.cell.2015.11.015
SSID ssj0000529419
Score 2.313479
Snippet Components of the type II CRISPR–Cas complex in bacteria have been used successfully in eukaryotic cells to facilitate rapid and accurate cell line...
Components of the type II CRISPR-Cas complex in bacteria have been used successfully in eukaryotic cells to facilitate rapid and accurate cell line...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 31782
SubjectTerms 38/47
38/77
49/23
631/154/555
631/1647/2163
631/208/191
631/208/69
631/67/68
Base Sequence
Cell Line, Tumor
CRISPR-Cas Systems
Gene Editing - methods
Gene Targeting - methods
Genetic Engineering - methods
Genetic Testing - methods
HEK293 Cells
HL-60 Cells
Humanities and Social Sciences
Humans
multidisciplinary
Reproducibility of Results
RNA, Guide, CRISPR-Cas Systems - genetics
Science
Science (multidisciplinary)
SummonAdditionalLinks – databaseName: HAS SpringerNature Open Access 2022
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bS8MwFD6MDVEfxLvzRnQ--FLsJWvSxzE25kCRzcHeSpKlKIy27ILszf_gP_SXeNq11TEFn_rQJG1ycnK-k5N8B-CmLjzBHVcaVNgOOijaMaTLpKE5o8p0PUulWUseHt3OgHaH9WEJavldmJX4fUrdjZYiRiPHcZ2tcJyPvAyVRqPb7xZbKUmwilpezhvk8Luizqq1WYOQ6ychi3DoNmzOw1gs3sR4_MPitHdhJ4OKpLGU7R6UdLgPG8vkkYsDaKFqJyfKsR2CKI7E31cASBSQJHeWHpFm777_1Pt8_2iKqUdGkyg2ovmM4GKBDixWPYRBu_Xc7BhZUgRDUcucGUwyIW0vYJzWPWVzLlMKMGFZSuETAR-uXkK4I8E9qnnAFSptYDnKdFC5uXSOoBxGoT4BgkIytS0kcyWjmkmPIhwQnNeDkUIUZVbhNh88X2WM4UniirGfRq4d7hfjXIXromi8pMn4rdBVLgEfJ3ESmRChjuZTH2EGGlI0orQKx0uJFM3YDEEeOo1VYCuyKgokBNmrb8LXl5QoG7059Cfxu7Vcqn6modPf_q5WCPzvPpz-q60z2EJg5SZ7z7Z9DuXZZK4vELzM5GU2eb8Avg_uCg
  priority: 102
  providerName: Springer Nature
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9swDCa6FMPQQx_rtqboBq3ZoRenfsiWfAyCFG2BBUG2ANnJkGQZHRbYRmJjyE79D_uH-yWln13WDOjJB1O2JErkR4j6CPDJFb7gjicNKmwHAxTtGNJj0tCcUWV6vqXKqiWfx971jN7O3Xl9WX1Vp1VWlJalmW6ywy7RX6To6jiGgWH0AnY9F6F3B3Zn48ngW1FADqGJgejAbtiDHP7YZtPnPAGST_Mh20PRPXiVx6lY_xSLxV9-5-oAxk2Pq3STH_08k3316x8yx2cP6RD2awRKBpXAEezo-DW8rGpSro9hhBajSFTHjhEEhyR9vFlAkogUJbl0SIbTmy-T6Z_730Ox8km4TFIjyTOCNgjjYmz6BmZXo6_Da6OutWAoapmZwSQT0vYjxqnrK5tzWTKLCctSCp-II9EoCuGFgvtU84grtAWR5SjTQZvBpfMWOnES6xMgqHtT20IyTzKqmfQpogzBuRuFCsGZ2YWLRhuBqonIi3oYi6A8EHd40M5MF85b0bRi39gm9LFRaYB7ozjwELFO8lWA6AX9M_pm2oV3lYrbz9gMsSPGol1gG8pvBQre7c038fe7kn8bg0QMU_G_vWaZBPXGX23rXa9dQf8fw-mzpM6gky1z_R5hUCY_1Iv_AdyKDXg
  priority: 102
  providerName: Unpaywall
Title Increasing the performance of pooled CRISPR–Cas9 drop-out screening
URI https://link.springer.com/article/10.1038/srep31782
https://www.ncbi.nlm.nih.gov/pubmed/27545104
https://www.proquest.com/docview/1813621234
https://pubmed.ncbi.nlm.nih.gov/PMC4992892
https://www.nature.com/articles/srep31782.pdf
UnpaywallVersion publishedVersion
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVFSB
  databaseName: Free Full-Text Journals in Chemistry
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: HH5
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://abc-chemistry.org/
  providerName: ABC ChemistRy
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: KQ8
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: Directory of Open Access Journals (DOAJ)
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: ABDBF
  dateStart: 20121221
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: DIK
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD : Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: RPM
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVAQT
  databaseName: Springer Nature - nature.com Journals - Fully Open Access
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: NAO
  dateStart: 20111201
  isFulltext: true
  titleUrlDefault: https://www.nature.com/siteindex/index.html
  providerName: Nature Publishing
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 20191231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: 7X7
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2045-2322
  dateEnd: 20191231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M48
  dateStart: 20110801
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVAVX
  databaseName: HAS SpringerNature Open Access 2022
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: AAJSJ
  dateStart: 20111201
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Open Access Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: C6C
  dateStart: 20111201
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwEB4tu0IsB8R7y6MyLAcugcRxY_uAUIm6WiptVXWpVE6R7ToCqUpCH4Le-A_8Q34J47zYaovEKVL8SOyxZ77xYz6AVz0llQgj7TFFQ3RQbOjpiGvPCs6MH8nAlKwlF6PofMqGs97sABqOzboDV3tdO8cnNV0u3vz4tn2PE_5ddWVcvEVbUqAZFKiJj9BAScfgcFGj_CrEN5WspPhwsdc9xBC0iTF0tfSuZboGN6-fmmy3Tm_DrU1WqO13tVhcsU5nd-FODStJvxoH9-DAZvfhZkU0uX0AA1QD7vQ51kMQ8ZHi73UBkqfE8WzZOYknHy_Hk98_f8VqJcl8mRdevlkTVCzo7GLRhzA9G3yKz72aQMEzLPDXHtdcaSpTLlhPGiqELsOFqSAwBp8IDlHTKRXNlZDMilQYnOBpEBo_REUgdPgIDrM8sydAUKC-pUrzSHNmuZYMoYMSopfODSIuvwOvm85LTB1d3JFcLJJylzsUSdvPHXjZZi2qkBr7Mr1oJJDggHe7GCqz-WaVICRBo4sGl3XgcSWRthrKERCig9kBviOrNoMLpr2bkn39UgbVRs8PfU_87mkj1aQZjPv-7rQV-L_b8OR_GvoUjhGDRW6ZmtJncLhebuxzxDlr3YUbfMa7cNTvDy-H-PwwGI0n-DaO4m65dtAtxzmmTEfj_uc_SQMDvg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3JTsMwEB1VIFQ4IHbKaigHLhFZ3Ng5oqhV2SoErdRbZLuOQKqSqItQb_wDf8iXMEmbQFWQOOUQe5J4Mp43HvsNwEVNeII7rjSosB0MULRjSJdJQ3NGlel6lsqqljy03GaH3nZr3RJU87Mwc_n7jLobPUWCTo7jPLuMAuyUIN93_WIhJU1VUcvLWYMcflX0mPc1CwBycR9kkQxdg_I4SsTkTfT7P_xNYwPWZ0CRXE81uwklHW3ByrR05GQb6mjY6X5ylEMQw5Hk-wAAiUOSVs7SPeI_3Tw_Pn2-f_hi6JHeIE6MeDwiOFVg-Ipdd6DTqLf9pjEriWAoapkjg0kmpO2FjNOap2zOZUYAJixLKbwi3MO5Swi3J7hHNQ-5QpMNLUeZDpo2l84uLEVxpPeBoIpMbQvJXMmoZtKjCAYE57WwpxBDmRW4zAcvUDO-8LRsRT_I8tYOD4pxrsB50TSZkmT81ugs10CAv3CalxCRjsfDAEEGulF0obQCe1ONFGJshhAPQ8YKsDldFQ1Seuz5O9HrS0aTjbEcRpP43Gqu1WBmn8Pf3q5aKPzvbzj4l6xTKDfbD_fB_U3r7hBWEWK56Sq0bR_B0mgw1scIY0byJPuNvwAKDu-V
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fT9swED9tIAZ7mNjGn24DzNgDL9GS2Imdx6pr1RaGUDukvkW242hIVRLRVog3vgPfkE-yy9-uKpP2lIfYF8fn8_3Od74D-ObJQArqK4tJl6KBYqilfK4sIzjTth84uqha8vPK79-w4cSbVJfVZ1VYZZnSstim6-iw76gvMlR1As3AKH4Nm4JTHxfxZrs9HA-bQ5XcbcWcoM4gRMWy36reWQOT6zGRjWP0LWwvkkw-3Mvp9C_d09uFdxVoJO1ymO_hlUk-wFZZRvLhI3RRyPPYcqRDEM-RbHkZgKQxyatomYh0RoPx9ej58akjZwGJ7tLMShdzgtsGmrLYdQ9uet1fnb5VlUewNHPsucUVl8oNYi6YF2hXCFUkA5OOozU-EfrhPialH0kRMCNioVF8Y4dqm6KYC0X3YSNJE3MIBNllG1cq7ivODFcBQ2AghfDiSCOesltwXk9eqKvc4XkJi2lY-LCpCJt5bsHXpmlWJsx4qdFpzYEQl3Puo5CJSRezEAEHqlRUp6wFByVHGjIuR7iH5mML-AqvmgZ5quzVN8nt7yJlNtp1aFnid89qroaVrM5eGt1Zw_B__8On_6J1Am-uf_TCy8HVxWfYQbTl5wfSrvsFNuZ3C3OEiGaujqt1_AcGHPZ8
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9swDCa6FMPQQx_rtqboBq3ZoRenfsiWfAyCFG2BBUG2ANnJkGQZHRbYRmJjyE79D_uH-yWln13WDOjJB1O2JErkR4j6CPDJFb7gjicNKmwHAxTtGNJj0tCcUWV6vqXKqiWfx971jN7O3Xl9WX1Vp1VWlJalmW6ywy7RX6To6jiGgWH0AnY9F6F3B3Zn48ngW1FADqGJgejAbtiDHP7YZtPnPAGST_Mh20PRPXiVx6lY_xSLxV9-5-oAxk2Pq3STH_08k3316x8yx2cP6RD2awRKBpXAEezo-DW8rGpSro9hhBajSFTHjhEEhyR9vFlAkogUJbl0SIbTmy-T6Z_730Ox8km4TFIjyTOCNgjjYmz6BmZXo6_Da6OutWAoapmZwSQT0vYjxqnrK5tzWTKLCctSCp-II9EoCuGFgvtU84grtAWR5SjTQZvBpfMWOnES6xMgqHtT20IyTzKqmfQpogzBuRuFCsGZ2YWLRhuBqonIi3oYi6A8EHd40M5MF85b0bRi39gm9LFRaYB7ozjwELFO8lWA6AX9M_pm2oV3lYrbz9gMsSPGol1gG8pvBQre7c038fe7kn8bg0QMU_G_vWaZBPXGX23rXa9dQf8fw-mzpM6gky1z_R5hUCY_1Iv_AdyKDXg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increasing+the+performance+of+pooled+CRISPR%E2%80%93Cas9+drop-out+screening&rft.jtitle=Scientific+reports&rft.au=Cross%2C+Benedict+C.+S.&rft.au=Lawo%2C+Steffen&rft.au=Archer%2C+Caroline+R.&rft.au=Hunt%2C+Jessica+R.&rft.date=2016-08-22&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=6&rft.issue=1&rft_id=info:doi/10.1038%2Fsrep31782&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_srep31782
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon